Experts Say Israel May Have Achieved Herd Immunity Against COVID-19
Click here to learn why “Israel is expected to be a very safe place for travelers” while the COVID-19 pandemic still rages on around the world.
Antibody Levels Remain High Two Months After Receiving the Second Dose of the COVID-19 Vaccine
According to the latest data, the Pfizer-BioNTech COVID-19 vaccine remains effective for at least two months after receiving the second jab. Click here to learn more.
New Sheba Study Indicates That Ivermectin Can Reduce the Length of COVID-19 Infection
Could Ivermectin Help Break the COVID-19 Transmission Chain? Click Here to Read About a New Sheba Study:
Positive Initial Results for Novel COVID-19 Drug Molnupiravir First Tested at Sheba
Initial clinical trial results indicate the efficacy of the novel COVID-19 drug Molnupiravir, first tested at Sheba.
Nonalcoholic Fatty Liver Disease
New Sheba study indicates that non-alcoholic fatty liver disease could increase the risk of COVID-19 mortality.
Revolutionary New Israeli Ventilation System
Israeli Advanced Ventilation Technology could help prevent ICU wards around the world from becoming overwhelmed as a result of the COVID-19 pandemic. Click here for the full story.
COVID-19 vaccine is highly effective
According to a new Sheba study, the Pfizer-BioNTech COVID-19 vaccine is highly effective: 98% saw a major increase in COVID-19 antibodies. Learn more.
